FIGSFIGS
FIGS
About: FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company markets and sells its products in the United States. Sales are generated through the Company's digital platforms.
Employees: 354
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
376% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $2.27M
28% more capital invested
Capital invested by funds: $672M [Q2] → $858M (+$186M) [Q3]
9% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 55
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
0.09% less ownership
Funds ownership: 77.7% [Q2] → 77.62% (-0.09%) [Q3]
9% less funds holding
Funds holding: 202 [Q2] → 184 (-18) [Q3]
35% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 37
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$4
33%
downside
Avg. target
$5.17
13%
downside
High target
$7
18%
upside
3 analyst ratings
0 positive
0%
2 neutral
67%
1 negative
33%
Goldman Sachs Brooke Roach 61% 1-year accuracy 22 / 36 met price target | 24%downside $4.50 | Sell Maintained | 10 Dec 2024 |
Telsey Advisory Group Dana Telsey 60% 1-year accuracy 114 / 190 met price target | 18%upside $7 | Market Perform Maintained | 13 Nov 2024 |
Barclays Adrienne Yih 51% 1-year accuracy 48 / 95 met price target | 33%downside $4 | Equal-Weight Maintained | 12 Nov 2024 |
Financial journalist opinion
Negative
Reuters
4 days ago
Scrubs maker Figs rebuffs Story3 Capital's take-private offer
Figs said on Thursday it has rebuffed private equity firm Story3 Capital Partners' offer to acquire the scrubs maker.
Positive
Invezz
2 weeks ago
Figs stock price sits in a range: will it have a breakout in 2025?
Figs stock has lost momentum and remained in a consolidation phase in almost two years. It remained inside the support and resistance levels at $4.42 and $6.97 in this period, missing the strong stock surge in the United States.
Neutral
Business Wire
1 month ago
Applied Fundamental Research Issues Open Letter to FIGS Management and its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Applied Fundamental Research, a long-term shareholder of FIGS, Inc. (NYSE: FIGS), has submitted an open letter to the company's management and its Board of Directors. The letter highlights FIGS' exceptional achievements in transforming the healthcare apparel market, expresses confidence in the company's ability to execute its growth strategy as a public company, and outlines recommendations for defining a clear capital allocation strategy to unlock shareholder.
Neutral
Business Wire
1 month ago
FIGS Announces Updates to Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Melanie Whelan, former Chief Executive Officer of SoulCycle Inc., to its board of directors (the “Board”), effective January 1, 2025 (the “Effective Date”). Ms. Whelan joins the Board as an independent director. Ms. Whelan has also been appointed to serve as Chair of the Board'.
Positive
Seeking Alpha
1 month ago
FIGS: Opportunistic Bid Grossly Undervalues A Recession Proof Business
An opportunistic offer by a PE fund during a 'retail lull' grossly undervalues FIGS, thus providing a chance for value and arbitrage investors to profit from the situation. Founded by Heather Hasson and Trina Spear, the stock has dropped from over $35 to $6.07 since its 2021 IPO and subsequent takeover offer. Story3 Capital's $6 per share offer to take the company private undervalues the business, which has strong free cash flow and no debt.
Neutral
The Motley Fool
1 month ago
Is Figs a Buy After $1 Billion Buyout Rumors?
Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.
Positive
WSJ
1 month ago
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm
The Story3 proposal values the company at more than $1 billion.
Positive
WSJ
1 month ago
Medical-Apparel Maker Figs Gets Takeover Bid From Private-Equity Firm
The Story3 proposal values the company at more than $1 billion.
Negative
Seeking Alpha
2 months ago
FIGS Back To Q1 Prices, But The Name Is Still A Hold
Figs reported disappointing 3Q24 results with a 2% revenue decline and a 13 percentage point drop in adjusted EBITDA margins, leading to a 30% stock price drop. The company's high SG&A expenses and lack of growth make it difficult to compete against lower-priced alternatives, justifying my Hold rating. Questionable $25 million investment in a pre-product healthcare education app raises concerns about capital allocation and potential conflicts of interest.
Neutral
Seeking Alpha
2 months ago
FIGS, Inc. (FIGS) Q3 2024 Earnings Call Transcript
FIGS, Inc. (NYSE:FIGS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Dana Telsey - Telsey Group Josh Reiss - Raymond James Bob Drbul - Guggenheim Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Nathan Feather - Morgan Stanley John Kernan - TD Cowen Ashley Owens - KeyBanc Capital Markets Operator Thank you for standing by, and good afternoon. Thank you for attending today's FIGS' Third Quarter Fiscal 2024 Earnings Conference Call.
Charts implemented using Lightweight Charts™